Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
| CAPS Rating |
|
|---|
SNSS
VS S&P 500 (SPY)
SNSS News and Commentary
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 – SeekingAlpha
- An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP – 247wallst
- Whoa! These Stocks Head-Faked the Market – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- The Highest-Rated Biopharma Stocks – The Motley Fool
- Smart Money Trends: 5 Biotech Stocks Being Bought Up By Insiders and Institutions – NASDAQ
- The 15 Most-Watched BioPharma Stocks – The Motley Fool
- Exelixis, YM Biosciences Lead Losers at Cancer Meeting – Minyanville
- To Partner or Not to Partner: That is the Question – SeekingAlpha
How do you think SNSS will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
70
Outperform
12
Underperform
All-Star Players
13
Outperform
5
Underperform
Wall Street
6
Outperform
0
Underperform
RSS Headlines
Fool UK
